Michael P. Tarnok - Net Worth and Insider Trading

Michael P. Tarnok Net Worth

The estimated net worth of Michael P. Tarnok is at least $1 Million dollars as of 2024-12-13. Michael P. Tarnok is the Director of Keryx Biopharmaceuticals Inc and owns about 328,600 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $1 Million. Details can be seen in Michael P. Tarnok's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael P. Tarnok has not made any transactions after 2015-05-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Michael P. Tarnok

To

Michael P. Tarnok Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael P. Tarnok owns 2 companies in total, including Dyadic International Inc (DYAI) , and Keryx Biopharmaceuticals Inc (KERX) .

Click here to see the complete history of Michael P. Tarnok’s form 4 insider trades.

Insider Ownership Summary of Michael P. Tarnok

Ticker Comapny Transaction Date Type of Owner
DYAI Dyadic International Inc 2019-06-25 director
KERX Keryx Biopharmaceuticals Inc 2015-06-17 director

Michael P. Tarnok Latest Holdings Summary

Michael P. Tarnok currently owns a total of 1 stock. Michael P. Tarnok owns 328,600 shares of Keryx Biopharmaceuticals Inc (KERX) as of May 6, 2015, with a value of $1 Million.

Latest Holdings of Michael P. Tarnok

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KERX Keryx Biopharmaceuticals Inc 2015-05-06 328,600 3.36 1,104,096

Holding Weightings of Michael P. Tarnok


Michael P. Tarnok Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael P. Tarnok has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the acquisition of 10,000 shares on May 6, 2015, which cost Michael P. Tarnok around $97,300.

Insider Trading History of Michael P. Tarnok

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael P. Tarnok Trading Performance

GuruFocus tracks the stock performance after each of Michael P. Tarnok's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael P. Tarnok is 35.88%. GuruFocus also compares Michael P. Tarnok's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael P. Tarnok within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael P. Tarnok's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael P. Tarnok

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 29.96 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 29.19 LIMIT LIMIT LIMIT LIMIT LIMIT

Michael P. Tarnok Ownership Network

Ownership Network List of Michael P. Tarnok

No Data

Ownership Network Relation of Michael P. Tarnok

Insider Network Chart

Michael P. Tarnok Owned Company Details

What does Dyadic International Inc do?

Who are the key executives at Dyadic International Inc?

Michael P. Tarnok is the director of Dyadic International Inc. Other key executives at Dyadic International Inc include VP of Research and Bus. Dvlpmt Ronen Tchelet , director & 10 percent owner & President & CEO & Chairman Mark A Emalfarb , and Chief Business Officer Joseph P Hazelton .

Dyadic International Inc (DYAI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dyadic International Inc (DYAI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dyadic International Inc (DYAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dyadic International Inc (DYAI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dyadic International Inc Insider Transactions

No Available Data

Michael P. Tarnok Mailing Address

Above is the net worth, insider trading, and ownership report for Michael P. Tarnok. You might contact Michael P. Tarnok via mailing address: Keryx Biopharmaceuticals, Inc., 750 Lexington Avenue, New York Ny 10022.